AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 196 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2024. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,648 | – | 90 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 825,473 | $18,317,246 | 17.56% |
| COWEN AND COMPANY, LLC | 4,288,366 | $95,158,841 | 9.95% |
| Cormorant Asset Management, LP | 2,762,115 | $61,291 | 4.10% |
| 5AM Venture Management, LLC | 665,555 | $14,768,665 | 3.97% |
| RTW INVESTMENTS, LP | 5,605,566 | $124,387,510 | 2.54% |
| RA Capital Management | 5,454,533 | $121,036,087 | 2.46% |
| COMMODORE CAPITAL LP | 590,705 | $13,108 | 1.98% |
| Avidity Partners Management LP | 3,275,000 | $72,672,250 | 1.57% |
| Casdin Capital, LLC | 850,000 | $18,861,500 | 1.46% |
| Boxer Capital, LLC | 1,121,327 | $24,882,246 | 1.31% |